Vera Therapeutics Inc (VERA)
37.98
+1.03
(+2.79%)
USD |
NASDAQ |
May 31, 16:00
37.98
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Cash and Short Term Investments (Annual): 160.72M for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 160.72M |
| December 31, 2022 | 114.65M |
| December 31, 2021 | 79.67M |
| Date | Value |
|---|---|
| December 31, 2020 | 53.65M |
| December 31, 2019 | 3.195M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
3.195M
Minimum
2019
160.72M
Maximum
2023
82.38M
Average
79.67M
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Vertex Pharmaceuticals Inc | 11.22B |
| Alpine Immune Sciences Inc (DELISTED) | 327.41M |
| Fate Therapeutics Inc | 315.18M |
| Mersana Therapeutics Inc | 209.08M |
| Equillium Inc | 40.87M |